Amphastar Pharmaceuticals (AMPH) just posted quarterly results that came in ahead of Wall Street estimates, drawing attention to both revenue growth and solid earnings. The company’s ongoing expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback